← Back to Search

Neuromodulation

Neuromodulation for Chronic Pain

N/A
Recruiting
Research Sponsored by Alberta Health Services, Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing whether electrical brain stimulation can help relieve chronic pain and other disorders.

Who is the study for?
This trial is for individuals who experience chronic pain and are candidates for a neuromodulation device implant, which they have agreed to receive. Participants must be able to communicate in English.Check my eligibility
What is being tested?
The study aims to test the effectiveness of different stimulation settings on a neuromodulation device that's implanted in patients with chronic pain conditions.See study design
What are the potential side effects?
While specific side effects aren't listed, typical risks may include discomfort at the implant site, potential infection, or changes in sensation due to varying stimulation parameters.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in baseline pain measures
Secondary outcome measures
Effect of stimulation on quality of life

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Industry standard stimulationActive Control1 Intervention
Industry standard stimulation settings
Group II: Experimental stimulationPlacebo Group1 Intervention
Experimental stimulation settings

Find a Location

Who is running the clinical trial?

Alberta Health Services, CalgaryLead Sponsor
13 Previous Clinical Trials
2,581 Total Patients Enrolled
1 Trials studying Chronic Pain
91 Patients Enrolled for Chronic Pain

Media Library

Stimulation parameters (Neuromodulation) Clinical Trial Eligibility Overview. Trial Name: NCT04933370 — N/A
Chronic Pain Research Study Groups: Industry standard stimulation, Experimental stimulation
Chronic Pain Clinical Trial 2023: Stimulation parameters Highlights & Side Effects. Trial Name: NCT04933370 — N/A
Stimulation parameters (Neuromodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04933370 — N/A
Chronic Pain Patient Testimony for trial: Trial Name: NCT04933370 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies for patients to participate in this research?

"The trial, which was announced on February 1st 2022 and last changed its status on the 14th of that same month, is currently in search for participants according to clinicaltrials.gov."

Answered by AI

Is the age range for this research project inclusive of senior citizens?

"In order to be eligible, potential participants need to reside between 18 and 100 years of age. There are 33 trials open for enrolment from those under the legal age and 363 studies that cater towards seniors."

Answered by AI

How many participants are currently undergoing treatment in this research endeavor?

"Affirmative. Clinicaltrials.gov has indicated that this clinical trial is open to participants, with the initial posting being published on February 1st 2022 and most recently edited on February 14th 2022. With only one site recruiting, there are 20 slots available for patients in total."

Answered by AI

Am I eligible to contribute to this research trial?

"The inclusion criteria for this trial requires that potential participants be between 18 and 100 years of age, suffering from chronic pain. Of these people, approximately 20 will be selected to take part in the study."

Answered by AI

Who else is applying?

What site did they apply to?
University of Calgary
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I have tried pain many medications, all resulted in zero relief. Pain clinic could not help me.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Neuromodulation Parameter Efficacy
Fady Girgis 2022. "Neuromodulation Parameter Efficacy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04933370.
All > Chronic Pain
~10 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top